JS004 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Combination of Toripalimab and JS004 Therapy for ccRCC
Clear Cell Renal Cell Carcinoma
Fudan University80 enrolled1 locationNCT06690697
Recruiting
Phase 2
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial
Limited Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China30 enrolled1 locationNCT06256237